Glutamate (Metabotropic) Group I Receptor Agonists
| Cat. No. | 产品名称/活性 |
|---|---|
| 0187 | (±)-trans-ACPD |
| Group I and II mGlu agonist | |
| 1049 | CHPG |
| mGlu5 selective agonist | |
| 3695 | CHPG Sodium salt |
| Selective mGlu5 agonist; sodium salt of CHPG (Cat. No. 1049) | |
| 0342 | (RS)-3,5-DHPG |
| Selective group I mGlu agonist | |
| 0805 | (S)-3,5-DHPG |
| Selective group I mGlu agonist; active enantiomer of 3,5-DHPG (Cat. No. 0342) | |
| 0188 | L-Quisqualic acid |
| Group I mGlu agonist; also AMPA agonist | |
| 0162 | S-Sulfo-L-cysteine sodium salt |
| Group I mGlu agonist |
mGlu Receptors Scientific Review
Our Metabotropic Glutamate Receptor review gives an overview of the pharmacological ligands used to study the mGlu receptors.
Request copyRequest PDFAddiction Life Science Poster
Written by Prof David Nutt, this poster summarizes the brain circuits and neurotransmitter systems that are affected by the main classes of addictive drugs.
Request copyDownload PDFDepression Life Science Poster
Written by P. Skolnich et al
Our Depression poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder.
Request copyDownload PDFHuntington's Disease Life Science Poster
Our Huntington's Disease (HD) poster summarizes the pathophysiology and molecular changes that occur in HD.
Request copyDownload PDFParkinson's Life Science Poster
Written by Anthony H.V. Schapira
Our Parkinson's disease (PD) poster summarizes the neurobiology of the disease, and highlights current therapeutic treatments for symptomatic PD.
Request copyDownload PDF